Commercial Credit Report for Accent Microcell Ltd

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Accent Microcell Ltd is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Accent Microcell Ltd

Phone: +91 7940042367p:+91 7940042367	AHMEDABAD, 380015 India	Ticker: ACCENTMICACCENTMIC

Business Summary

Accent Microcell Limited is engaged in developing, processing, refining, producing, manufacturing, or buying, importing, stocking, and marketing, selling, exporting, and generally dealing in all kinds of drugs and medicines. The Company’s segments include Pharmaceuticals, Nutraceuticals, and Food. Its drugs and medicines include bulk drugs, pharmaceutical formulations in all forms, feed supplements and dietary food supplements and food preparations in allopathic, ayurvedic, umami, homeopathic or other branches of healthcare and treatment of human beings and veterinary applications, antibiotics, herbal, bacteriological and biological products, insecticides, pesticides, fungicides, disinfectants and vermin fugs and raw materials, ingredients, intermediates, semi-finished or finished preparations, compounds, pharmaceutical chemical and microcrystalline cellulose powder, alpha cellulose powder and all kinds of products and by-products.

(Source: N-30D)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
9/30/2024	3/31/2024	-	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations

General Information

Number of Employees:	174	(As of 3/31/2024)
Outstanding Shares:	21,043,000	(As of 9/30/2024)
Stock Exchange:	NSE

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN